C12N 2760/14222
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/14222 (New viral proteins or individual genes, new structural or functional aspects of) appears on 26 US grants and 43 published applications in this corpus.
Search patents in C12N- Granted patents
- 26
- Published applications
- 43
- Assignees
- 31
- Inventors
- 81
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 2 |
| 2006 | 3 | 3 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 2 | 3 |
| 2011 | 1 | 0 |
| 2012 | 3 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 1 | 5 |
| 2018 | 1 | 2 |
| 2019 | 1 | 1 |
| 2020 | 1 | 4 |
| 2021 | 1 | 2 |
| 2022 | 3 | 2 |
| 2023 | 4 | 3 |
| 2024 | 0 | 3 |
| 2025 | 1 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Vaccines and uses thereof to induce an immune response to SARS-CoV217 Mar 2026US 12,577,589 B2GeoVax, Inc.
- Marburgvirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same8 Apr 2025US 12,268,735 B2The Trustees of the University of Pennsylvania
- Compositions and methods of manufacturing trivalent filovirus vaccines3 Oct 2023US 11,771,757 B2Soligenix, Inc.
- Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same15 Aug 2023US 11,723,969 B2The Trustees of the University of Pennsylvania
- Stabilized Filovirus glycoprotein trimers14 Mar 2023US 11,603,390 B2Janssen Vaccines & Prevention B. V.
- Vaccines and methods6 Aug 2026US 2026/0224686 A1Cambridge Enterprise Limited
- Viral constructs for use in enhancing t-cell priming during vaccination17 Oct 2024US 2024/0344082 A1GeoVax, Inc.
- Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines13 Jun 2024US 2024/0189413 A1Soligenix, Inc.
- Filovirus Consensus Antigens, Nucleic Acid Constructs And Vaccines Made Therefrom, And Methods Of Using Same28 Mar 2024US 2024/0100143 A1The Trustees of the University of Pennsylvania
- Marburgvirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same21 Sep 2023US 2023/0293664 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Development of a preventive vaccine for filovirus infection in primates20US 7,094,598 B2The United States of America as represented by the Department of Health and Human Services · 2006
- Generation of virus-like particles and use as panfilovirus vaccine20US 7,682,618 B2The United States of America as represented by the Secretary of the Army · 2010
- Development of a preventive vaccine for filovirus infection in primates10US 8,106,026 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2012
- Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same10US 9,597,388 B2The Trustees of the University of Pennslyvania · 2017
- Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same4US 10,034,930 B2The Trustees of the University of Pennsylvania · 2018